Loratadine Tablet
Product Images NDC 58602-702

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loratadine (NDC 58602-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (10 mg (45 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (10 mg Container Carton (45 Tablets))

Package Label-principal Display Panel (10 mg Container Carton (45 Tablets))
Loratadine Tablets USP 10 mg is an antihistamine used for temporary relief of symptoms such as sneezing, runny nose, itchy throat or nose, and itchy or watery eyes due to indoor or outdoor allergies. The medication is manufactured by Baver Healthcare, LLC and contains lactose monohydrate, magnesium stearate, and microcrystalline cellulose as inactive ingredients. It is not recommended for children under 6 years of age with kidney or liver disease. If you experience an allergic reaction to the medication, contact the Poison Control Center right away. If the Tamper-evident seal is missing, do not use. The medication should be stored at room temperature, protected from moisture. If you have any concerns, speak with your healthcare provider.*
FDA Label Image

Package Label-principal Display Panel (10 mg Blister Carton (30 Tablets))

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.